A Long-Term, Open-Label Safety and Maintenance of Efficacy Study of JZP-110[(R)-2-amino3-phenylpropylcarbamate hydrochloride] in the Treatment of Excessive Sleepiness in subjects with Narcolepsy or Obstructive Sleep Apnea

Administered By

Awarded By

Contributors

Start/End

  • September 1, 2015 - April 18, 2018